|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,615.00 KRW | -3.35% |
|
-5.04% | -32.33% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.35% | -5.04% | -47.20% | - | 72.25M | ||
| -2.45% | -0.68% | +73.14% | +485.18% | 39.3B | ||
| -2.16% | -2.16% | +7.88% | +33.35% | 22.77B | ||
| -2.24% | +2.10% | -20.83% | -37.85% | 7.46B | ||
| -3.30% | -0.05% | +18.56% | +110.22% | 5.16B | ||
| +1.88% | +2.08% | +13.68% | +40.82% | 2.88B | ||
| +0.31% | -8.49% | -23.00% | +1,097.45% | 1.95B | ||
| -1.79% | -4.88% | +91.14% | -9.76% | 1.85B | ||
| +0.16% | -8.73% | +26.76% | -24.86% | 1.68B | ||
| -1.03% | -0.45% | +19.27% | -4.94% | 1.62B | ||
| Average | -1.40% | -1.03% | +15.94% | +187.73% | 8.48B | |
| Weighted average by Cap. | -2.10% | -0.33% | +38.12% | +263.33% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















